2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Trickler WJ et al. | Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. | 2010 | AAPS PharmSciTech | pmid:20238190 |
| Souza C et al. | Effect of Liquid Crystalline Systems Containing Antimicrobial Compounds on Infectious Skin Bacteria. | 2017 | AAPS PharmSciTech | pmid:28028794 |
| Lian R et al. | Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability. | 2011 | AAPS PharmSciTech | pmid:21948306 |
| Madheswaran T et al. | Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants. | 2014 | AAPS PharmSciTech | pmid:24222268 |
| Rachmawati H et al. | Intraoral film containing insulin-phospholipid microemulsion: formulation and in vivo hypoglycemic activity study. | 2015 | AAPS PharmSciTech | pmid:25511810 |
| Trivino A et al. | Drug-Lipid-Surfactant Miscibility for the Development of Solid Lipid Nanoparticles. | 2019 | AAPS PharmSciTech | pmid:30617602 |
| Li Q et al. | Cubic Liquid Crystalline Gels Based on Glycerol Monooleate for Intra-articular Injection. | 2018 | AAPS PharmSciTech | pmid:29027137 |
| Jain S et al. | Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles. | 2018 | AAPS PharmSciTech | pmid:28785860 |
| Lai J et al. | Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. | 2009 | AAPS PharmSciTech | pmid:19636709 |